This is the Stago Group’s parent brand. It developed its first reagents in the 1960s, and in 1988 launched its first analyser, which already incorporated Stago’s gold standard Viscosity-based Detection System (VSD). Today, Stago is a leading brand and global reference in Haemostasis, with a strong international presence encompassing more than 120 countries. Its range of systems and reagents covers all the needs of Haemostasis laboratories, from routine labs to research labs, including dynamic Thrombin Generation assays.
Tcoag acts in synergy with the Stago brand, offering a product range incorporating two measurement technologies clotting (mechanical and optical), for which the targeted market positioning is based on local conditions. This brand resulted from the Stago Group’s purchase in 2010 of Trinity Biotech’s coagulation business, which itself resulted from the coming together of several top names in the coagulation world. The first Tcoag system developed after joining the Stago Group was the DT 100.
Based on its experience and well-established products, the Stago Group created this exclusive new brand to meet the needs of China’s small and small to medium-sized hospital segment. It proposes three systems — Emo Step 4, Emo Smart and Emo Express — with a range of routine reagents, controls, calibrators, disposables and auxiliary reagents. This product line derives purely from the Group’s in-house R&D and production, and meets all “Stago Quality” standards.
The biotech company BioCytex originated in the La Timone/La Conception university hospital complex in Marseilles, France in the early 1990s, and joined the Stago Group in 1994. Specialised in the development of standardised kits for quantitative flow cytometry in cellular Haemostasis, BioCytex works in particular on platelet analysis, but also on leukocyte and red blood cell analysis.
Agro-Bio is a research subsidiary of the Stago Group, offering biotech solutions and specific products for the life sciences sector since its creation in 1975. Its areas of operation and expertise cover immunotechnology, proteomics and platelet aggregation for public and private sector research clients. The heart of its activity is the development and production of antibodies.
The Synapse research institute grew out of Maastricht University in the Netherlands, and is a specialist and pioneer in global assays relating to Thrombin Generation. Its research programme leads it to cooperate with a variety of partners from the pharmaceutical industry and health sector. The Synapse team includes doctors, pharmacists, biochemists and engineers, whose complementary skills enable it to undertake both basic and applied research in order to design and develop new products.
It is then the role of Thrombinoscope to finalise these innovations and prepare them for the market. Founded in 2004, again as a spin-off from Maastricht University, Thrombinoscope joined the Stago Group in 2009, with its flagship system for Thrombin Generation analysis: the CAT.